RA Capital Management - C4 THERAPEUTICS INC ownership

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 85 filers reported holding C4 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of C4 THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$44,358,000
-27.9%
1,377,5690.0%0.78%
-8.3%
Q3 2021$61,550,000
+18.1%
1,377,5690.0%0.85%
+1.9%
Q2 2021$52,127,000
+2.3%
1,377,5690.0%0.84%
+9.0%
Q1 2021$50,956,000
+11.7%
1,377,5690.0%0.77%
+20.4%
Q4 2020$45,639,0001,377,5690.64%
Other shareholders
C4 THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,642,210$14,402,0001.72%
Soleus Capital Management, L.P. 1,441,513$12,642,0001.72%
Nextech Invest Ltd. 375,857$3,296,0001.06%
RTW INVESTMENTS, LP 2,819,472$24,727,0000.57%
ArrowMark Colorado Holdings LLC 5,091,975$44,657,0000.55%
WASATCH ADVISORS LP 5,934,476$52,045,0000.36%
HARBOR CAPITAL ADVISORS, INC. 25,470$223,0000.20%
Perceptive Advisors 766,231$6,720,0000.20%
DRIEHAUS CAPITAL MANAGEMENT LLC 606,721$5,321,0000.08%
Virtus ETF Advisers LLC 19,305$169,0000.07%
View complete list of C4 THERAPEUTICS INC shareholders